Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

421
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
421
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-I: Introduction01:29

Asthma-I: Introduction

2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

273
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
273
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early response toward clinical remission with dupilumab in severe asthma: Real-world cohort.

The journal of allergy and clinical immunology. Global·2026
Same author

Anisakis allergy beyond elimination: High cooked-fish clinical tolerability and diagnostic value of two-stage ani sIgE.

Allergology international : official journal of the Japanese Society of Allergology·2026
Same author

Beyond "Pancake Syndrome": Oral Mite Anaphylaxis Caused by High-Protein Fish Stock Powder.

Journal of investigational allergology & clinical immunology·2026
Same author

Outcomes following the discontinuation of biologic therapy in patients with severe asthma.

Allergology international : official journal of the Japanese Society of Allergology·2026
Same author

Variations in the perceived value of anti-SARS-CoV-2 therapeutics based on physicians' clinical backgrounds.

Scientific reports·2026
Same author

Reply to Finsterer: Why HAPE Was the Most Likely Diagnosis in This Case.

Internal medicine (Tokyo, Japan)·2026

Related Experiment Video

Updated: Jul 13, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

31.9K

Clinical inertia in asthma.

Yosuke Fukuda1,2, Tetsuya Homma3, Hironori Sagara3

  • 1Department of Medicine, Division of Respiratory Medicine, Yamanashi Red Cross Hospital, 6663-1 Funatsu, Fujikawaguchiko-machi, Yamanashi, Japan. yosukefukuda.showa@gmail.com.

NPJ Primary Care Respiratory Medicine
|October 14, 2023
PubMed
Summary

Many asthma patients lack adequate control, leading to poor quality of life. Addressing clinical inertia (CI) through multifaceted strategies like the M-GAP approach can improve asthma management.

More Related Videos

Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

27.7K
A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
09:58

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 13, 2010

22.5K

Related Experiment Videos

Last Updated: Jul 13, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

31.9K
Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

27.7K
A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
09:58

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 13, 2010

22.5K

Area of Science:

  • Pulmonology
  • Healthcare Management

Background:

  • Asthma remains poorly controlled in many patients despite recent pharmaceutical advances.
  • This lack of control results in chronic disability, reduced quality of life, and increased healthcare utilization (emergency visits, hospitalizations).

Purpose of the Study:

  • To highlight the critical role of clinical inertia (CI) in suboptimal asthma management.
  • To categorize the different types of CI and propose strategies for overcoming them.

Main Methods:

  • The study conceptualizes clinical inertia (CI) into three main categories: healthcare provider-related, patient-related, and healthcare system-related.
  • It introduces the M-GAP approach as a strategy to address these CI.

Main Results:

  • Clinical inertia is a significant barrier to effective asthma management.
  • The M-GAP approach offers a framework for improving asthma control.

Conclusions:

  • Overcoming clinical inertia requires a multifaceted strategy.
  • The M-GAP approach, integrating multidisciplinary care, guideline dissemination, application use, and affordable prescriptions, can enhance asthma management and improve patient outcomes.